We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov Menu

Phacoemulsification Under Topical Anesthesia and Its Complications

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: June 27, 2011
Last Update Posted: June 27, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Instituto de Oftalmologia Ivo Correa-Meyer
The purpose of this study is to determine if topical anesthesia is safe for phacoemulsification in eyes with comorbidities.

Condition Intervention Phase
Phacoemulsification Procedure: Phacoemulsification Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Instituto de Oftalmologia Ivo Correa-Meyer:

Primary Outcome Measures:
  • Number of Postoperative events [ Time Frame: 12 months ]
    To describe any postoperatives events in a phacoemulsification surgery under topical anesthesia

Estimated Enrollment: 111
Study Start Date: January 2006
Study Completion Date: April 2011
Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Topical anesthesia Procedure: Phacoemulsification
Phacoemulsification under topical anesthesia


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • patients with cataract with a visual acuity less than 0.8

Exclusion Criteria:

  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Manuel Augusto Pereira Vilela, Instituto de Oftalmologia Ivo Correa-Meyer
ClinicalTrials.gov Identifier: NCT01381783     History of Changes
Other Study ID Numbers: facectopica
First Submitted: April 7, 2011
First Posted: June 27, 2011
Last Update Posted: June 27, 2011
Last Verified: March 2011

Keywords provided by Instituto de Oftalmologia Ivo Correa-Meyer:
topical anaesthesia

Additional relevant MeSH terms:
Central Nervous System Depressants
Physiological Effects of Drugs

To Top